Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia

Elizabeth A. Hibler, Chengcheng Hu, Peter Jurutka, Maria E. Martinez, Elizabeth T. Jacobs

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Vitamin D levels and calcium intake have been associated with risk of colorectal neoplasia, and genetic variation in vitamin D pathway genes may affect circulating vitamin D metabolite concentrations and/or risk for colorectal lesions. This study evaluated associations between polymorphic variation in the Gc-globulin (GC) and calcium-sensing receptor (CASR) and odds for metachronous colorectal neoplasia and vitamin D metabolite concentrations. Methods: Participants from the Ursodeoxycholic Acid (UDCA) and Wheat Bran Fiber (WBF) trials (n =1,439) were analyzed using a single-nucleotide polymorphism (SNP) tagging approach, with a subset (n=404) of UDCA trial participants for whom vitamin Dmetabolite concentrations were also available. A total of 25 GC and 35 CASR tag SNPs were evaluated using multiple statistical methods. Results: Principal components analyses did not reveal gene-level associations between GC or CASR and colorectal neoplasia; however, a significant gene-level association between GC and 25(OH)D concentrations (P < 0.01) was observed. At the individual SNP level and following multiple comparisons adjustments, significant associations were observed between seven GC (rs7041, rs222035, rs842999, rs1155563, rs12512631, rs16846876, and rs1746825) polymorphisms and circulating measures of 25(OH)D (adjusted P < 0.01) and CASR SNP rs1042636 and proximal colorectal neoplasia (adjusted P = 0.01). Conclusions: These results show a possible association between variation in CASR and odds of colorectal neoplasia as well as the potential role of variation in GC with circulating 25(OH)D concentrations. Impact: Additional research is warranted to determine the mechanism of GC genotype in influencing 25(OH) D concentrations and to further elucidate the role of CASR in colorectal neoplasia.

Original languageEnglish (US)
Pages (from-to)368-375
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume21
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Calcium-Sensing Receptors
Vitamin D
Single Nucleotide Polymorphism
Genes
Ursodeoxycholic Acid
Neoplasms
Vitamin D-Binding Protein
Dietary Fiber
Principal Component Analysis
Vitamins
Genotype
Calcium
Research

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. / Hibler, Elizabeth A.; Hu, Chengcheng; Jurutka, Peter; Martinez, Maria E.; Jacobs, Elizabeth T.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 21, No. 2, 02.2012, p. 368-375.

Research output: Contribution to journalArticle

@article{d81968cdedbd44c5ad4db7e60f3ad70b,
title = "Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia",
abstract = "Background: Vitamin D levels and calcium intake have been associated with risk of colorectal neoplasia, and genetic variation in vitamin D pathway genes may affect circulating vitamin D metabolite concentrations and/or risk for colorectal lesions. This study evaluated associations between polymorphic variation in the Gc-globulin (GC) and calcium-sensing receptor (CASR) and odds for metachronous colorectal neoplasia and vitamin D metabolite concentrations. Methods: Participants from the Ursodeoxycholic Acid (UDCA) and Wheat Bran Fiber (WBF) trials (n =1,439) were analyzed using a single-nucleotide polymorphism (SNP) tagging approach, with a subset (n=404) of UDCA trial participants for whom vitamin Dmetabolite concentrations were also available. A total of 25 GC and 35 CASR tag SNPs were evaluated using multiple statistical methods. Results: Principal components analyses did not reveal gene-level associations between GC or CASR and colorectal neoplasia; however, a significant gene-level association between GC and 25(OH)D concentrations (P < 0.01) was observed. At the individual SNP level and following multiple comparisons adjustments, significant associations were observed between seven GC (rs7041, rs222035, rs842999, rs1155563, rs12512631, rs16846876, and rs1746825) polymorphisms and circulating measures of 25(OH)D (adjusted P < 0.01) and CASR SNP rs1042636 and proximal colorectal neoplasia (adjusted P = 0.01). Conclusions: These results show a possible association between variation in CASR and odds of colorectal neoplasia as well as the potential role of variation in GC with circulating 25(OH)D concentrations. Impact: Additional research is warranted to determine the mechanism of GC genotype in influencing 25(OH) D concentrations and to further elucidate the role of CASR in colorectal neoplasia.",
author = "Hibler, {Elizabeth A.} and Chengcheng Hu and Peter Jurutka and Martinez, {Maria E.} and Jacobs, {Elizabeth T.}",
year = "2012",
month = "2",
doi = "10.1158/1055-9965.EPI-11-0916",
language = "English (US)",
volume = "21",
pages = "368--375",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia

AU - Hibler, Elizabeth A.

AU - Hu, Chengcheng

AU - Jurutka, Peter

AU - Martinez, Maria E.

AU - Jacobs, Elizabeth T.

PY - 2012/2

Y1 - 2012/2

N2 - Background: Vitamin D levels and calcium intake have been associated with risk of colorectal neoplasia, and genetic variation in vitamin D pathway genes may affect circulating vitamin D metabolite concentrations and/or risk for colorectal lesions. This study evaluated associations between polymorphic variation in the Gc-globulin (GC) and calcium-sensing receptor (CASR) and odds for metachronous colorectal neoplasia and vitamin D metabolite concentrations. Methods: Participants from the Ursodeoxycholic Acid (UDCA) and Wheat Bran Fiber (WBF) trials (n =1,439) were analyzed using a single-nucleotide polymorphism (SNP) tagging approach, with a subset (n=404) of UDCA trial participants for whom vitamin Dmetabolite concentrations were also available. A total of 25 GC and 35 CASR tag SNPs were evaluated using multiple statistical methods. Results: Principal components analyses did not reveal gene-level associations between GC or CASR and colorectal neoplasia; however, a significant gene-level association between GC and 25(OH)D concentrations (P < 0.01) was observed. At the individual SNP level and following multiple comparisons adjustments, significant associations were observed between seven GC (rs7041, rs222035, rs842999, rs1155563, rs12512631, rs16846876, and rs1746825) polymorphisms and circulating measures of 25(OH)D (adjusted P < 0.01) and CASR SNP rs1042636 and proximal colorectal neoplasia (adjusted P = 0.01). Conclusions: These results show a possible association between variation in CASR and odds of colorectal neoplasia as well as the potential role of variation in GC with circulating 25(OH)D concentrations. Impact: Additional research is warranted to determine the mechanism of GC genotype in influencing 25(OH) D concentrations and to further elucidate the role of CASR in colorectal neoplasia.

AB - Background: Vitamin D levels and calcium intake have been associated with risk of colorectal neoplasia, and genetic variation in vitamin D pathway genes may affect circulating vitamin D metabolite concentrations and/or risk for colorectal lesions. This study evaluated associations between polymorphic variation in the Gc-globulin (GC) and calcium-sensing receptor (CASR) and odds for metachronous colorectal neoplasia and vitamin D metabolite concentrations. Methods: Participants from the Ursodeoxycholic Acid (UDCA) and Wheat Bran Fiber (WBF) trials (n =1,439) were analyzed using a single-nucleotide polymorphism (SNP) tagging approach, with a subset (n=404) of UDCA trial participants for whom vitamin Dmetabolite concentrations were also available. A total of 25 GC and 35 CASR tag SNPs were evaluated using multiple statistical methods. Results: Principal components analyses did not reveal gene-level associations between GC or CASR and colorectal neoplasia; however, a significant gene-level association between GC and 25(OH)D concentrations (P < 0.01) was observed. At the individual SNP level and following multiple comparisons adjustments, significant associations were observed between seven GC (rs7041, rs222035, rs842999, rs1155563, rs12512631, rs16846876, and rs1746825) polymorphisms and circulating measures of 25(OH)D (adjusted P < 0.01) and CASR SNP rs1042636 and proximal colorectal neoplasia (adjusted P = 0.01). Conclusions: These results show a possible association between variation in CASR and odds of colorectal neoplasia as well as the potential role of variation in GC with circulating 25(OH)D concentrations. Impact: Additional research is warranted to determine the mechanism of GC genotype in influencing 25(OH) D concentrations and to further elucidate the role of CASR in colorectal neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=84857099369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857099369&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-11-0916

DO - 10.1158/1055-9965.EPI-11-0916

M3 - Article

C2 - 22144504

AN - SCOPUS:84857099369

VL - 21

SP - 368

EP - 375

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 2

ER -